EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Utilization of Nitrogen-Doped Graphene Quantum Dots to Neutralize ROS and Modulate Intracellular Antioxidant Pathways to Improve Dry Eye Disease Therapy

Zixia Wu, Weibo Xia, Liling Ou, Ling Zheng, Bingying Hou, Tonghe Pan, Wenjie Sun, Leo H Koole, Yongqing Shao, Lei Qi iD

International Journal of Nanomedicine · 2024-03 · Volume 19 · 2691-2708

DOI: 10.2147/ijn.s445398 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Nanomedicine, 2024-03. Verfasst von Zixia Wu und 9 weiteren Autor:innen. Beteiligte Einrichtung: National Engineering Research Center of Ophthalmology and Optometry, Eye Hospital, Wenzhou Medical University, Wenzhou, 325027, the People's Republic…. Hauptthemen laut MEDLINE: Graphite, Quantum Dots, Dry Eye Syndromes, Polyethylenes. Die Arbeit wurde bisher 33-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Patients afflicted with dry eye disease (DED) experience significant discomfort. The underlying cause of DED is the excessive accumulation of ROS on the ocular surface. Here, we investigated the nitrogen doped-graphene quantum dots (NGQDs), known for their ROS-scavenging capabilities, as a treatment for DED.

Methods

NGQDs were prepared by using citric acid and urea as precursors through hydrothermal method. The antioxidant abilities of NGQDs were evaluated through: scavenging the ROS both extracellular and intracellular, regulating the nuclear factor-erythroid 2-related factor (Nrf2) antioxidant pathway of human corneal epithelial cells (HCECs) and their transcription of inflammation related genes. Furthermore, NGQDs were modified by Arg-Gly-Asp-Ser (RGDS) peptides to obtain RGDS@NGQDs. In vivo, both the NGQDs and RGDS@NGQDs were suspended in 0.1% Pluronic F127 (w/v) and delivered as eye drops in the scopolamine hydrobromide-induced DED mouse model. Preclinical efficacy was compared to the healthy and DPBS treated DED mice.

Results

These NGQDs demonstrated pronounced antioxidant properties, efficiently neutralizing free radicals and activating the intracellular Nrf2 pathway. In vitro studies revealed that treatment of H2O2-exposed HCECs with NGQDs induced a preservation in cell viability. Additionally, there was a reduction in the transcription of inflammation-associated genes. To prolong the corneal residence time of NGQDs, they were further modified with RGDS peptides and suspended in 0.1% Pluronic F127 (w/v) to create RGDS@NGQDs F127 eye drops. RGDS@NGQDs exhibited superior intracellular antioxidant activity even at low concentrations (10 μg/mL). Subsequent in vivo studies revealed that RGDS@NGQDs F127 eye drops notably mitigated the symptoms of DED mouse model, primarily by reducing ocular ROS levels.

Conclusion

Our findings underscore the enhanced antioxidant benefits achieved by modifying GQDs through nitrogen doping and RGDS peptide tethering. Importantly, in a mouse model, our novel eye drops formulation effectively ameliorated DED symptoms, thereby representing a novel therapeutic pathway for DED management.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GraphiteQuantum DotsDry Eye SyndromesPolyethylenesPolypropylenesMiceHumansAnimalsAntioxidantsReactive Oxygen SpeciesNitrogenHydrogen PeroxideNF-E2-Related Factor 2PoloxamerInflammationOphthalmic SolutionsPeptides

Stichwörter der Autor:innen

Nrf2 antioxidant pathwayantioxidantdry eye diseasenitrogen doped graphene quantum dots

Substanzen

AntioxidantsReactive Oxygen SpeciesGraphiteNitrogenHydrogen PeroxideUCON 50-HB-5100NF-E2-Related Factor 2PoloxamerOphthalmic SolutionsPeptides

Autor:innen und Institutionen

  • National Engineering Research Center of Ophthalmology and Optometry, Eye Hospital, Wenzhou Medical University, Wenzhou, 325027, the People's Republic of China.
  • Ningbo Eye Hospital, Affiliated to Wenzhou Medical University, Ningbo, Zhejiang, 310000, the People's Republic of China.

ORCID-Profile: Lei Qi

Zitieren

APA

Wu, Z., Xia, W., Ou, L., Zheng, L., Hou, B., Pan, T., Sun, W., Koole, L. H., Shao, Y., & Qi, L. (2024). Utilization of Nitrogen-Doped Graphene Quantum Dots to Neutralize ROS and Modulate Intracellular Antioxidant Pathways to Improve Dry Eye Disease Therapy. International Journal of Nanomedicine, Volume 19, 2691-2708. https://doi.org/10.2147/ijn.s445398

Vancouver

Wu Z, Xia W, Ou L, Zheng L, Hou B, Pan T, et al. Utilization of Nitrogen-Doped Graphene Quantum Dots to Neutralize ROS and Modulate Intracellular Antioxidant Pathways to Improve Dry Eye Disease Therapy. International Journal of Nanomedicine. 2024;Volume 19:2691-2708. doi:10.2147/ijn.s445398

BibTeX
@article{Wu2024,
  author = {Wu, Zixia and Xia, Weibo and Ou, Liling and Zheng, Ling and Hou, Bingying and Pan, Tonghe and Sun, Wenjie and Koole, Leo H and Shao, Yongqing and Qi, Lei},
  title = {Utilization of Nitrogen-Doped Graphene Quantum Dots to Neutralize ROS and Modulate Intracellular Antioxidant Pathways to Improve Dry Eye Disease Therapy},
  journal = {International Journal of Nanomedicine},
  year = {2024},
  volume = {Volume 19},
  pages = {2691--2708},
  doi = {10.2147/ijn.s445398}
}
Kostenlos starten →